Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Next-Generation Sequencing (NGS) technology has revolutionized the field of Human Leukocyte Antigen (HLA) typing, which is critical for organ transplantation, disease association studies, and immune response research. NGS offers a powerful, precise, and efficient approach for high resolution HLA typing, improving the matching process in transplantation and enhancing our understanding of the genetic foundations of the immune system.
Many labs might find NGS difficult to adopt due to the increased complexity, dedicated labor requirements and data management challenges. Laboratory throughput influences the strategy used in consolidating genotyping technologies.
We offer a comprehensive portfolio that meets the diverse needs of the HLA genotyping market and our One Lambda NGS assays are designed for simplicity and flexibility allowing laboratories greater cross-training on their platform of choice.
Not all products are CE marked or have 510(k) clearance for sale in the US. Availability of product in each country depends on local regulatory marketing authorization status. Not all products are available in all countries. Please consult your local sales representative for details.